FDA approves EOS imaging online 3D spine surgery planning solution

Paris-based medical imaging company EOS imaging announced today that its spineEOS software—an online 3D tool for spine surgery planning—has received FDA approval.

The software allows surgeons to create treatment strategies from pelvic and vertebral 3D data resulting from an EOS exam, which can in turn be used to formulate a plan based on the exact shape and length of the spinal implants.

“We believe that patients’ spines are complex 3D systems that need a personalized 3D planning of the intended surgery,” said ESO imaging CEO, Marie Meynadier, in a press release. “We look forward to this next important step toward our broader goal of expanding our EOSapps planning software suite to better connect imaging to patient care.”

Approval of the software allows the company to continue its expansion into the growing U.S. spine market, which includes approximately 400,000 patients per year at an orthopedic implant value of $3 billion.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.